Meng-xia Zhang
651 Dongfeng East Road
Guangzhou, 510060, China
Guangzhou, 510060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Efficacy of sequential chemoradiotherapy combined with toripalimab in de novo metastatic nasopharyngeal carcinoma: A phase II trial.
Journal: Cell reports. Medicine
Published: March 17, 2023
Gemcitabine combined with apatinib and toripalimab in recurrent or metastatic nasopharyngeal carcinoma.
Journal: Med (New York, N.Y.)
Published: March 08, 2022
Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study.
Journal: Therapeutic advances in medical oncology
Published: January 22, 2022
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma.
Journal: Frontiers in oncology
Published: February 22, 2021
The impact of induction chemotherapy on long-term quality of life in patients with locoregionally advanced nasopharyngeal carcinoma: Outcomes from a randomised phase 3 trial.
Journal: Oral oncology
Published: January 10, 2021
Erratum: Oncogenic roles of carbonic anhydrase IX in human nasopharyngeal carcinoma.
Journal: International journal of clinical and experimental pathology
Published: September 17, 2020
LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma.
Journal: Frontiers in oncology
Published: September 13, 2020
Transoral Robotic Retropharyngeal Lymph Node Dissection in Nasopharyngeal Carcinoma With Retropharyngeal Lymph Node Recurrence.
Journal: The Laryngoscope
Published: July 29, 2020
ZBTB7A functioned as an oncogene in colorectal cancer.
Journal: BMC gastroenterology
Published: July 28, 2020
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma.
Journal: Cancer communications (London, England)
Published: June 13, 2019
Last Updated: 09/26/2026